课题基金 / 基金详情

METTL10/PIAS3/MITF信号通路在胃癌发生发展中的机制研究

批准号:
82072727
项目类别:
面上项目
资助金额:
55.0 万元
负责人:
洪雪辉
依托单位:
学科分类:
肿瘤细胞命运
结题年份:
2024
批准年份:
2020
项目状态:
已结题
项目参与者:
洪雪辉

项目摘要

结项摘要

洪雪辉的其他基金

相似基金

相关文献

中文摘要
胃癌(GC)是我国高发的恶性肿瘤,幽门螺杆菌(H.pylori)感染是GC的首要发病原因,然而其导致GC发生的机制仍不明确。申请人前期通过代谢组学分析,发现H.pylori感染的GC细胞嘌呤代谢显著增强,进一步RNA-seq分析证实METTL10表达异常升高;预实验证实METTL10在GC中高表达,促进GC细胞增殖和迁移,并介导嘌呤合成代谢关键转录因子MITF的表达;初步机制研究提示METTL10能够结合并甲基化PIAS3,抑制其对MITF泛素化降解;同时,METTL10启动子区存在MITF的结合位点。据此,我们提出假说:METTL10/PIAS3/MITF信号轴及自身环路通过嘌呤代谢调控H.pylori介导的GC发生发展。本项目拟通过分子生物学、动物模型及临床标本验证该假设,研究结论将为H.pylori相关GC的治疗提供靶点及理论依据。
英文摘要
Gastric cancer (GC) is one of the malignant tumors with high incidence in China. H.pylori was considers as the dominant pathogen of GC. However, the underlying mechanism still remains to be determined. We analyzed the metabolomics of GC cell infected with or without H.pylori and found that purine metabolism was comprehensively enhanced. Further RNA-seq analysis revealed that METTL10 was highly expressed. Preliminary data showed that METTL10 was overexpressed in GC, promoted GC cell proliferation and migration. Furthermore, METTL10 facilitated the expression of MITF, a crucial transcriptional factor of purine de novo biosynthesis. Primary mechanic study indicated that METTL10 could potentially interact and methylate PIAS3, which disrupt the ubiquitination of MITF by PIAS3. Meanwhile, MITF could bind to the promoter of METTL10. Collectively, we hypothesized that METTL10/PIAS3/MITF signal pathway plays a critical role in H.pylori mediated GC progression by regulating purine metabolism. By using molecular biology tools, mice model and clinical specimens, we will validate the role of METTL10/PIAS3/MITF feedback loop in GC progression. Our study will provide a novel theoretical basis as well as new drug targets for H.pylori related GC.
核苷酸代谢重编程在胃癌(Gastric Cancer,GC)的发展过程中扮演着重要角色,然而其中的调控机制及其对GC进展的具体影响仍不明确。在本研究中,我们发现甲基转移酶样10(METTL10)是胃肿瘤形成的关键调控因子,其通过增强胃癌细胞中的嘌呤核苷酸代谢发挥作用。具体而言,METTL10在赖氨酸442残基处甲基化活化STAT3的蛋白质抑制蛋白(PIAS3),从而干扰PIAS3与小眼畸形相关转录因子(MITF)的相互作用。这一过程导致PIAS3对MITF的SUMO化和泛素化作用减弱,进而稳定MITF并激活嘌呤代谢。值得注意的是,MITF的积累和PIAS3-K442的甲基化都是METTL10发挥致癌作用所必需的,且这两个因素均与GC的不良临床预后密切相关。此外,我们还合成并筛选了一种化合物LZQ-02-023-01,它能够有效诱导METTL10介导的MITF泛素化和降解,从而抑制METTL10的致癌活性。我们的研究结果表明,METTL10在嘌呤核苷酸代谢重编程中起关键作用,进而促进胃癌的发生。因此,METTL10有望成为胃癌治疗的潜在靶点。
TCL1/WTX/β-Catenin信号通路调控上皮间质转化促进结直肠癌侵袭转移的分子机制研究
  • 批准号:
    81602149
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    19.0万元
  • 批准年份:
    2016
  • 负责人:
    洪雪辉
  • 依托单位:
国内基金
海外基金